Intraventricular pentosan polysulphate in human prion diseases: an observational study in the UK
- PMID: 18355301
- DOI: 10.1111/j.1468-1331.2008.02108.x
Intraventricular pentosan polysulphate in human prion diseases: an observational study in the UK
Abstract
BACKGROUND, PURPOSE AND METHODS: This observational study assessed the effect of continuous intraventricular infusion of pentosan polysulphate (PPS) in seven patients at different clinical centres in the UK.
Results: Complications of intraventricular catheterization were frequent. PPS was well-tolerated over a wide dose range (11-110 microg/kg/day) during the 6-month study. Four patients were assessed for the entire study period: one remained stable, two showed minimal deterioration and one progressed significantly.
Conclusion: Mean survival of all patients was longer than reported values for natural history of specific prion disorders. Possible reasons for these findings are explored.
Comment in
-
Creutzfeldt-Jakob disease: hopes for therapy.Eur J Neurol. 2008 May;15(5):435-6. doi: 10.1111/j.1468-1331.2008.02109.x. Eur J Neurol. 2008. PMID: 18394045 No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical